Gainers
- Gossamer Bio (NASDAQ:GOSS) shares moved upwards by 47.2% to $0.29 during Tuesday's pre-market session. The company's market cap stands at $97.4 million.
- Prelude Therapeutics (NASDAQ:PRLD) shares moved upwards by 20.3% to $4.68. The market value of their outstanding shares is at $309.8 million.
- ProMIS Neurosciences (NASDAQ:PMN) stock increased by 16.46% to $13.65. The company's market cap stands at $105.1 million.
- Aldeyra Therapeutics (NASDAQ:ALDX) shares moved upwards by 11.04% to $1.76. The company's market cap stands at $95.6 million.
- Altimmune (NASDAQ:ALT) stock rose 8.8% to $3.22. The market value of their outstanding shares is at $575.6 million.
- IQVIA Holdings (NYSE:IQV) shares rose 8.76% to $231.9. The company's market cap stands at $35.5 billion. As per the news, the Q2 earnings report came out today.
Losers
- Replimune Group (NASDAQ:REPL) shares fell 24.7% to $6.5 during Tuesday's pre-market session. The company's market cap stands at $724.4 million.
- Nexalin Technology (NASDAQ:NXL) stock decreased by 16.29% to $0.37. The market value of their outstanding shares is at $9.7 million.
- BiomX (AMEX:PHGE) shares decreased by 12.92% to $0.17. The market value of their outstanding shares is at $2.1 million.
- Outlook Therapeutics (NASDAQ:OTLK) shares decreased by 11.92% to $0.94. The company's market cap stands at $158.2 million.
- Autonomix Medical (NASDAQ:AMIX) shares fell 11.83% to $2.46. The company's market cap stands at $1.5 million.
- China SXT Pharmaceuticals (NASDAQ:SXTC) shares decreased by 11.61% to $0.06. The company's market cap stands at $2.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Login to comment